Biblio Discovery — Demo Discovery Service

12 results

Showing 1–12 · 0.15 seconds · RSS

Journal

American Journal of Psychiatry

Scopus

ISSN 0002-953X · American Psychiatric Association · 12 articles in the index

  1. Journal Article

    Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD

    Margaret H. Sibley; L. Eugene Arnold; James M. Swanson et al.

    American Journal of Psychiatry · 2021 · English · OpenAlex Scopus

    OBJECTIVE: It is estimated that childhood attention deficit hyperactivity disorder (ADHD) remits by adulthood in approximately 50% of cases; however, this conclusion is typically based on single endpoints, failing to consider longitudinal patterns of ADHD expression. The authors investigated the…

  2. Journal Article

    Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Roger S. McIntyre; Joshua Daniel Rosenblat; Charles B. Nemeroff et al.

    American Journal of Psychiatry · 2021 · English · OpenAlex Scopus

    Replicated international studies have underscored the human and societal costs associated with major depressive disorder. Despite the proven efficacy of monoamine-based antidepressants in major depression, the majority of treated individuals fail to achieve full syndromal and functional recovery…

  3. Journal Article

    Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder

    Wayne K. Goodman; Eric A. Storch; Sameer Anil Sheth

    American Journal of Psychiatry · 2021 · English · OpenAlex Scopus

    Obsessive-compulsive disorder (OCD) is a common, chronic, and oftentimes disabling disorder. The only established first-line treatments for OCD are exposure and response prevention, and serotonin reuptake inhibitor medications (SRIs). However, a subset of patients fails to respond to either…

  4. Journal Article

    Neuroimaging Biomarkers in Schizophrenia

    Nina Vanessa Kraguljac; William Maffitt McDonald; Alik S. Widge et al.

    American Journal of Psychiatry · 2021 · English · OpenAlex Scopus

    Schizophrenia is a complex neuropsychiatric syndrome with a heterogeneous genetic, neurobiological, and phenotypic profile. Currently, no objective biological measures—that is, biomarkers—are available to inform diagnostic or treatment decisions. Neuroimaging is well positioned for biomarker…

  5. Journal Article

    From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States

    Deidre M. Anglin; Sabrina Ereshefsky; Mallory J. Klaunig et al.

    American Journal of Psychiatry · 2021 · English · OpenAlex Scopus

    The authors examine U.S.-based evidence that connects characteristics of the social environment with outcomes across the psychosis continuum, from psychotic experiences to schizophrenia. The notion that inequitable social and economic systems of society significantly influence psychosis risk…

  6. Journal Article

    Identification of Common Neural Circuit Disruptions in Emotional Processing Across Psychiatric Disorders

    Lisa M. McTeague; Benjamin M. Rosenberg; James W. Lopez et al.

    American Journal of Psychiatry · 2020 · English · OpenAlex Scopus

    OBJECTIVE: Disrupted emotional processing is a common feature of many psychiatric disorders. The authors investigated functional disruptions in neural circuitry underlying emotional processing across a range of tasks and across psychiatric disorders through a transdiagnostic quantitative…

  7. Journal Article

    Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation

    Shan H. Siddiqi; Stephan Floyd Taylor; Danielle Cooke et al.

    American Journal of Psychiatry · 2020 · English · OpenAlex Scopus

    OBJECTIVE: Treatment of different depression symptoms may require different brain stimulation targets with different underlying brain circuits. The authors sought to identify such targets, which could improve the efficacy of therapeutic brain stimulation and facilitate personalized therapy…

  8. Journal Article

    Reproducible Genetic Risk Loci for Anxiety: Results From ∼200,000 Participants in the Million Veteran Program

    Daniel F. Levey; Joel E. Gelernter; Renato A Polimanti et al.

    American Journal of Psychiatry · 2020 · English · OpenAlex Scopus

    Objective: Anxiety disorders are common and often disabling. The goal of this study was to examine the genetic architecture of anxiety disorders and anxiety symptoms, which are also frequently comorbid with other mental disorders, such as major depressive disorder. Methods: Using one of the world’s…

  9. Journal Article

    An Exposure-Wide and Mendelian Randomization Approach to Identifying Modifiable Factors for the Prevention of Depression

    Karmel W. Choi; Murray B. Stein; Kristen M. Nishimi et al.

    American Journal of Psychiatry · 2020 · English · OpenAlex Scopus

    OBJECTIVE: Efforts to prevent depression, the leading cause of disability worldwide, have focused on a limited number of candidate factors. Using phenotypic and genomic data from over 100,000 UK Biobank participants, the authors sought to systematically screen and validate a wide range of potential…

  10. Journal Article Full text

    Hormonal Treatments for Major Depressive Disorder: State of the Art

    Jennifer B. Dwyer; Awais Aftab; Rajiv Radhakrishnan et al.

    American Journal of Psychiatry · 2020 · English · OpenAlex Scopus

    Major depressive disorder is a common psychiatric disorder associated with marked suffering, morbidity, mortality, and cost. The World Health Organization projects that by 2030, major depression will be the leading cause of disease burden worldwide. While numerous treatments for major depression…

  11. Journal Article Full text

    20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings

    Taeho Greg Rhee; Mark Olfson; Andrew Alan Nierenberg et al.

    American Journal of Psychiatry · 2020 · English · OpenAlex Scopus

    OBJECTIVE: Pharmacological options for treating bipolar disorder have increased over the past 20 years, with several second-generation antipsychotics receiving regulatory approval in the 1990s. The authors describe trends in use of pharmacological agents in the outpatient management of bipolar…